Page last updated: 2024-10-29

avapro and DDD MPGNII

avapro has been researched along with DDD MPGNII in 2 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sahin, G1
Korkmaz, C1
Işiksoy, S1
Yalçin, AU1
Colucci, G1
Manno, C1
Grandaliano, G1
Schena, FP1

Other Studies

2 other studies available for avapro and DDD MPGNII

ArticleYear
Autoimmune hypothyroidism and lupus-like syndrome.
    Rheumatology international, 2010, Volume: 30, Issue:4

    Topics: Adult; Arthritis; Azathioprine; Biphenyl Compounds; Complement C3; Complement C4; Complement System

2010
Cryoglobulinemic membranoproliferative glomerulonephritis: beyond conventional therapy.
    Clinical nephrology, 2011, Volume: 75, Issue:4

    Topics: Adrenal Cortex Hormones; Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, No

2011